Strontium ranelate: A novel mode of action leading to renewed bone quality
- 2 December 2004
- journal article
- review article
- Published by Springer Nature in Osteoporosis International
- Vol. 16 (S01) , S11-S15
Abstract
Various bone resorption inhibitors and bone stimulators have been shown to decrease the risk of osteoporotic fractures. However, there is still a need for agents promoting bone formation by inducing positive uncoupling between bone formation and bone resorption. In vitro studies have suggested that strontium ranelate enhances osteoblast cell replication and activity. Simultaneously, strontium ranelate dose-dependently inhibits osteoclast activity. In vivo studies indicate that strontium ranelate stimulates bone formation and inhibits bone resorption and prevents bone loss and/or promotes bone gain. This positive uncoupling between bone formation and bone resorption results in bone gain and improvement in bone geometry and microarchitecture, without affecting the intrinsic bone tissue quality. Thus, all the determinants of bone strength are positively influenced. In conclusion, strontium ranelate, a new treatment of postmenopausal osteoporosis, acts through an innovative mode of action, both stimulating bone formation and inhibiting bone resorption, resulting in the rebalancing of bone turnover in favor of bone formation. Strontium ranelate increases bone mass while preserving the bone mineralization process, resulting in improvement in bone strength and bone quality.Keywords
This publication has 49 references indexed in Scilit:
- Morphological and Mechanical Properties of Bone Structural Units: A Two-Case Study.JSME International Journal Series C, 2002
- The Influence of Combined Parathyroid Hormone and Growth Hormone Treatment on Cortical Bone in Aged Ovariectomized RatsJournal of Bone and Mineral Research, 2000
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Growth hormone stimulates bone formation and strength of cortical bone in aged ratsJournal of Bone and Mineral Research, 1995
- Response of femoral neck to estrogen depletion and parathyroid hormone in aged ratsBone, 1995
- PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)—assessed in sexually mature, ovariectomized ratsBone, 1994
- Human parathyroid hormone (1–34) and (1–84) increase the mechanical strength and thickness of cortical bone in ratsJournal of Bone and Mineral Research, 1993
- Fluoride therapy in postmenopausal osteopenic women: Effect on vertebral and femoral bone density and prediction of bone responseOsteoporosis International, 1991
- Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormoneBone, 1991
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990